Home » Topics » Regulatory » Patents

Patents
RSS

Bristol-Myers Squibb has patented GPR40 modulators

Nov. 26, 2015

University of California, Oakland divulges UT-A inhibitors

Nov. 26, 2015

Kissei Pharmaceutical discloses NK1 receptor antagonists

Nov. 26, 2015

Global Blood Therapeutics develops kallikrein inhibitors

Nov. 26, 2015

University of Ulster describes apelin receptor agonists

Nov. 25, 2015

Lycera presents ROR-gamma agonists

Nov. 25, 2015

Bristol-Myers Squibb reports GPR40 modulators

Nov. 25, 2015

University of Colorado discloses TLR2 agonists

Nov. 25, 2015

Orion develops GABA-B receptor PAMs

Nov. 25, 2015

Sunshine Lake Pharma patents 5-HT reuptake inhibitors

Nov. 25, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026